Clinical Trials
6 trialsNCT03448393 2025-06-04
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01460498 2020-03-05
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01471067 2017-04-28
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00428909 2016-04-21
Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Novartis
Phase 1 Completed
NCT00420043 2016-04-05
Effect of Food on Bioavailability of Modified Release Formulations of Imatinib
Novartis
Phase 1 Completed
NCT00422825 2016-04-05
Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib
Novartis
Phase 1 Completed